Torvutatug samrotecan
- Listing at source
- Listed
- Drug name
- Torvutatug samrotecan
- azd5335
- AZD5335
- torvutatug samrotecan
- Torvutatug samrotecan
- FDA ingredient codes (UNII)
- E5QZ8ZF3HE
Related records
Trials (3)
- Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
- Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Homologous Recombination Deficiency (HRD) Negative Advanced Epithelial Ovarian Cancer
- Torvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian Cancer